TODA KAZUYA,戸田 一弥,SHIMODA HIROSHI,下田 博司,MURAI HIROMICHI,村井 弘道
申请号：
JP2015154729
公开号：
JP2017031120A
申请日:
2015.08.05
申请国别(地区):
JP
年份:
2017
代理人:
摘要：
PROBLEM TO BE SOLVED: To provide novel gene silencing agents of TNF-α and IL-6 which are attributed to exercise-induced skeletal muscle damage.SOLUTION: The present invention relates to (1) a TNF-α gene silencing agent containing Kaempferia parviflora extract as an active ingredient (2) an IL-6 gene silencing agent containing Kaempferia parviflora extract as an active ingredient (3) an exercise-induced skeletal muscle damage-caused muscle inflammatory inhibitor which contains the agent (1) or (2) as an active ingredient (4) a myalgia ameliorating agent containing any one of the agents (1) to (3) as an active ingredient and (5) a muscle fatigue ameliorating agent containing any one of the agents (1) to (3) as an active ingredient.SELECTED DRAWING: NoneCOPYRIGHT: (C)2017,JPO&INPIT【課題】運動誘発性骨格筋損傷に起因する新規なTNF-α及びIL-6の遺伝子発現抑制剤の提供。【解決手段】(1)黒ショウガ抽出物を有効成分とするTNF-α遺伝子発現抑制剤。(2)黒ショウガ抽出物を有効成分とするIL-6遺伝子発現抑制剤。(3)前記(1)又は(2)の剤を有効成分とする運動誘発性骨格筋損傷に起因する筋肉炎症抑制剤。(4)前記(1)~(3)のいずれか1つの剤を有効成分とする筋肉痛改善剤。(5)前記(1)~(3)のいずれか1つの剤を有効成分とする筋肉疲労改善剤。【選択図】なし
